C. Neil Lyons
Directeur/Membre du Conseil chez Panacela Labs, Inc.
Profil
C.
Neil Lyons is currently the Director at Panacela Labs, Inc. He previously worked as the CFO, Treasurer, CAO & Head-Investor Relations at RegeneRx Biopharmaceuticals, Inc. from 2005 to 2011.
He also worked as the Chief Financial Officer at HFS, Inc. and Vice President-Finance at SkyBridge LP.
From 1996 to 1998, he was a Senior Financial Executive at Bell Atlantic Corp.
He received his undergraduate degree from Florida Southern College.
Postes actifs de C. Neil Lyons
| Sociétés | Poste | Début |
|---|---|---|
Panacela Labs, Inc.
 Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | Directeur/Membre du Conseil | 01/04/2014 |
Anciens postes connus de C. Neil Lyons
| Sociétés | Poste | Fin |
|---|---|---|
| STATERA BIOPHARMA, INC. | Directeur Financier/CFO | 06/05/2016 |
| REGENERX BIOPHARMACEUTICALS, INC. | Directeur Financier/CFO | 31/08/2011 |
| HFS, Inc. | Directeur Financier/CFO | 20/04/2005 |
| SkyBridge LP | Directeur Financier/CFO | 01/01/2003 |
| Bell Atlantic Corp. | Corporate Officer/Principal | 01/01/1998 |
Formation de C. Neil Lyons
| Florida Southern College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
| HFS, Inc. | Commercial Services |
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | Health Technology |
| Bell Atlantic Corp. | Communications |
| SkyBridge LP |
